101 related articles for article (PubMed ID: 8418263)
1. Thallium scintigraphy in the evaluation of mass abnormalities of the breast.
Waxman AD; Ramanna L; Memsic LD; Foster CE; Silberman AW; Gleischman SH; Brenner RJ; Brachman MB; Kuhar CJ; Yadegar J
J Nucl Med; 1993 Jan; 34(1):18-23. PubMed ID: 8418263
[TBL] [Abstract][Full Text] [Related]
2. 201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography.
Vural G; Atasever T; Ozdemir A; Oznur I; Karabacak NI; Gökçora N; Işik S; Unlü M
Nuklearmedizin; 1997 Dec; 36(8):282-8. PubMed ID: 17068879
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of palpable breast masses with 201Tl scintigraphy.
Rebollo AC; Torres-Avisbal M; Espinosa JE; Diaz C; Vallejo JA; Pacheco C; Pera C; Mateo A
Br J Radiol; 1995 Oct; 68(814):1052-7. PubMed ID: 7496703
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of palpable breast masses with 201TI scintigraphy.
Roebuck DJ
Br J Radiol; 1996 Aug; 69(824):785-6. PubMed ID: 8949685
[No Abstract] [Full Text] [Related]
5. Comparison of indium-111 octreotide and thallium-201 scintigraphy in patients mammographically suspected of having breast cancer: preliminary results.
Vural G; Unlü M; Atasever T; Ozur I; Ozdemir A; Gökçora N
Eur J Nucl Med; 1997 Mar; 24(3):312-5. PubMed ID: 9143470
[TBL] [Abstract][Full Text] [Related]
6. The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography.
Cimitan M; Volpe R; Candiani E; Gusso G; Ruffo R; Borsatti E; Massarut S; Rossi C; Morassut S; Carbone A
Eur J Nucl Med; 1995 Oct; 22(10):1110-7. PubMed ID: 8542893
[TBL] [Abstract][Full Text] [Related]
7. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses.
Kao CH; Wang SJ; Liu TJ
Eur J Nucl Med; 1994 May; 21(5):432-6. PubMed ID: 8062849
[TBL] [Abstract][Full Text] [Related]
8. 99Tcm-tetrofosmin scintigraphy in the evaluation of palpable breast masses.
Adalet I; Demirkol MO; Müslümanoğlu M; Bozfakioğlu Y; Cantez S
Nucl Med Commun; 1997 Feb; 18(2):118-21. PubMed ID: 9076766
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of thallium-201 SPECT scintimammography to differentiate benign from malignant breast masses in mammographically dense breasts.
Chiou JF; Lin MC; Chen DR; Jim YF; Kao CH
Cancer Invest; 2003; 21(6):863-8. PubMed ID: 14735690
[TBL] [Abstract][Full Text] [Related]
10. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
Ramanna L; Waxman A; Braunstein G
J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
[TBL] [Abstract][Full Text] [Related]
11. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer.
Lee VW; Sax EJ; McAneny DB; Pollack S; Blanchard RA; Beazley RM; Kavanah MT; Ward RJ
J Nucl Med; 1993 Dec; 34(12):2095-100. PubMed ID: 8254394
[TBL] [Abstract][Full Text] [Related]
12. The role of breast scintigraphy in detecting breast masses.
Khayat G; Achram M; Rizk G
Br J Radiol; 1985 Aug; 58(692):721-4. PubMed ID: 3842276
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of spot compression-magnification and tangential views in mammographic evaluation of palpable breast masses.
Faulk RM; Sickles EA
Radiology; 1992 Oct; 185(1):87-90. PubMed ID: 1523339
[TBL] [Abstract][Full Text] [Related]
14. Delayed Tc-99m citrate scintigraphy in the evaluation of palpable breast masses.
Mondal A; Sharma R; Chakravarty KL; Mishra P; Sahay K; Bhatnagar A; Gupta A; Sawroop K
Clin Nucl Med; 1999 May; 24(5):309-13. PubMed ID: 10232466
[TBL] [Abstract][Full Text] [Related]
15. Comparing thallium-201 spect mammoscintigraphy and ultrasonography to detect breast cancer in mammographical dense breasts.
Chen DR; Jeng LB; Kao A; Lin CC; Lee CC
Neoplasma; 2003; 50(3):222-6. PubMed ID: 12937857
[TBL] [Abstract][Full Text] [Related]
16. 201ti scintigraphy in postoperative detection of thyroid cancer: a comparative study with 131i.
Tonami N; Hisada K
Radiology; 1980 Aug; 136(2):461-4. PubMed ID: 7403524
[TBL] [Abstract][Full Text] [Related]
17. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors.
Sumiya H; Taki J; Tsuchiya H; Nonomura A; Miyauchi T; Tonami N
J Nucl Med; 1998 Sep; 39(9):1600-4. PubMed ID: 9744351
[TBL] [Abstract][Full Text] [Related]
18. Follow-up study of postoperative patients with thyroid cancer by thallium-201 scintigraphy and serum thyroglobulin measurement.
Iida Y; Hidaka A; Hatabu H; Kasagi K; Konishi J
J Nucl Med; 1991 Nov; 32(11):2098-100. PubMed ID: 1941144
[TBL] [Abstract][Full Text] [Related]
19. Thallium-201-chloride thyroid scintigraphy to evaluate benign and/or malignant nodules: usefulness of the delayed scan.
Ochi H; Sawa H; Fukuda T; Inoue Y; Nakajima H; Masuda Y; Okamura T; Onoyama Y; Sugano S; Ohkita H; Tei Y; Kamino K; Kobayashi Y
Cancer; 1982 Jul; 50(2):236-40. PubMed ID: 7083130
[TBL] [Abstract][Full Text] [Related]
20. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?
Graf O; Helbich TH; Fuchsjaeger MH; Hopf G; Morgun M; Graf C; Mallek R; Sickles EA
Radiology; 2004 Dec; 233(3):850-6. PubMed ID: 15486217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
